UB Paderborn / Katalog / Suche / in CDI

Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy

Human molecular genetics, 2012-07, Vol.21 (14), p.3237-3254

2012

Volltextzugriff (PDF)

EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM): A prospective observational study on incidence of arrhythmias

Journal of cardiovascular electrophysiology, 2021-01, Vol.32 (1), p.129-135

2021

Volltextzugriff (PDF)

Genetic variants in cardiac calcification in Northern Sweden

Medicine (Baltimore), 2019-04, Vol.98 (15), p.e15065-e15065

2019

Volltextzugriff (PDF)

Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis

Journal of clinical medicine, 2020-09, Vol.9 (10), p.3062

2020

Volltextzugriff (PDF)

Genetic screening in sudden cardiac death in the young can save future lives

International journal of legal medicine, 2016-01, Vol.130 (1), p.59-66

2016

Volltextzugriff (PDF)

EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM)—rationale and design: a prospective observational study on incidence of arrhythmias in Sweden

BMJ open, 2017-12, Vol.7 (12), p.e019541-e019541

2017

Volltextzugriff (PDF)

Diagnosis of left ventricular hypertrophy using non-ECG-gated 15O-water PET

Journal of nuclear cardiology, 2022-10, Vol.29 (5), p.2361-2373

2022

Volltextzugriff (PDF)

Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery

Journal of cardiovascular electrophysiology, 2015-10, Vol.26 (10), p.1088-1094

2015

Volltextzugriff (PDF)

Risk Markers and Appropriate Implantable Defibrillator Therapy in Hypertrophic Cardiomyopathy

Pacing and clinical electrophysiology, 2016-03, Vol.39 (3), p.291-301

2016

Volltextzugriff (PDF)

Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators

Health and quality of life outcomes, 2016-04, Vol.14 (62), p.62-62, Article 62

2016

Volltextzugriff (PDF)

Impaired left ventricular systolic function reserve limits cardiac output and exercise capacity in HFpEF patients due to systemic hypertension

International journal of cardiology, 2013-09, Vol.168 (2), p.1088-1093

2013

Volltextzugriff (PDF)

Living with hypertrophic cardiomyopathy and an implantable defibrillator

BMC cardiovascular disorders, 2017-05, Vol.17 (1), p.121-121, Article 121

2017

Volltextzugriff (PDF)

Should variants of unknown significance (VUS) be disclosed to patients in cardiogenetics or not; only in case of high suspicion of pathogenicity?

European journal of human genetics : EJHG, 2022-11, Vol.30 (11), p.1208-1210

2022

Volltextzugriff (PDF)

Misclassification of hypertrophic cardiomyopathy: validation of diagnostic codes

Clinical epidemiology, 2017-01, Vol.9, p.403-410

2017

Volltextzugriff (PDF)

Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy

Human molecular genetics, 2012-07, Vol.21 (14), p.3237-3254

2012

Volltextzugriff (PDF)

Using OPLS-DA to find new hypotheses in vast amounts of gene expression data — Studying the progression of cardiac hypertrophy in the heart of aorta ligated rat

Gene, 2013-06, Vol.522 (1), p.27-36

2013

Volltextzugriff (PDF)

Long anterior mitral leaflet causing outflow tract obstruction in a symptomatic patient with hypertrophic cardiomyopathy: The role of mitral valve surgical correction

International journal of cardiology, 2016-02, Vol.204, p.86-87

2016

Volltextzugriff (PDF)

The Normal Impact of Age and Gender on Right Heart Structure and Function

Echocardiography (Mount Kisco, N.Y.), 2014-01, Vol.31 (1), p.5-11

2014

Volltextzugriff (PDF)

Positron emission tomography (15O-water, 11C-acetate, 11C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy

International journal of cardiology. Heart & vasculature, 2020-02, Vol.26 (26), p.100452-100452, Article 100452

2020

Volltextzugriff (PDF)

Myocardial capillary supply is limited in hypertrophic cardiomyopathy: A morphological analysis

International journal of cardiology, 2008-05, Vol.126 (2), p.252-257

2008

Volltextzugriff (PDF)

Long mitral valve leaflets determine left ventricular outflow tract obstruction during exercise in hypertrophic cardiomyopathy

International journal of cardiology, 2016-06, Vol.212, p.47-53

2016

Volltextzugriff (PDF)

Growth factor stimulation of cardiomyocytes induces changes in the transcriptional contents of secreted exosomes

Journal of extracellular vesicles, 2013-01, Vol.2 (1), p.1-n/a

2013

Volltextzugriff (PDF)

Causes of death and mortality in hypertrophic cardiomyopathy patients with implantable defibrillators in Sweden

Journal of cardiovascular medicine (Hagerstown, Md.), 2016-07, Vol.17 (7), p.478

2016

Volltextzugriff (PDF)

Arrhythmogenic left ventricular apical aneurysm in hypertrophic cardiomyopathy

International journal of cardiology, 2011-08, Vol.151 (1), p.e8-e9

2011

Volltextzugriff (PDF)

Low Molecular Mass Myocardial Hyaluronan in Human Hypertrophic Cardiomyopathy

Cells (Basel, Switzerland), 2019-01, Vol.8 (2), p.97

2019

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy

EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM): A prospective observational study on incidence of arrhythmias

Genetic variants in cardiac calcification in Northern Sweden

Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis

Genetic screening in sudden cardiac death in the young can save future lives

EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM)—rationale and design: a prospective observational study on incidence of arrhythmias in Sweden

Diagnosis of left ventricular hypertrophy using non-ECG-gated 15O-water PET

Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery

Risk Markers and Appropriate Implantable Defibrillator Therapy in Hypertrophic Cardiomyopathy

Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators

Impaired left ventricular systolic function reserve limits cardiac output and exercise capacity in HFpEF patients due to systemic hypertension

Living with hypertrophic cardiomyopathy and an implantable defibrillator

Should variants of unknown significance (VUS) be disclosed to patients in cardiogenetics or not; only in case of high suspicion of pathogenicity?

Misclassification of hypertrophic cardiomyopathy: validation of diagnostic codes

Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy

Using OPLS-DA to find new hypotheses in vast amounts of gene expression data — Studying the progression of cardiac hypertrophy in the heart of aorta ligated rat

Long anterior mitral leaflet causing outflow tract obstruction in a symptomatic patient with hypertrophic cardiomyopathy: The role of mitral valve surgical correction

The Normal Impact of Age and Gender on Right Heart Structure and Function

Positron emission tomography (15O-water, 11C-acetate, 11C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy

Myocardial capillary supply is limited in hypertrophic cardiomyopathy: A morphological analysis

Long mitral valve leaflets determine left ventricular outflow tract obstruction during exercise in hypertrophic cardiomyopathy

Growth factor stimulation of cardiomyocytes induces changes in the transcriptional contents of secreted exosomes

Causes of death and mortality in hypertrophic cardiomyopathy patients with implantable defibrillators in Sweden

Arrhythmogenic left ventricular apical aneurysm in hypertrophic cardiomyopathy

Low Molecular Mass Myocardial Hyaluronan in Human Hypertrophic Cardiomyopathy

Suchergebnisse filtern